Taf + Emtricitabine + Elvitegravir + Cobicistat Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg

Reference Brands: Genvoya(US & EU)

Category: Anti Viral

TAF + Emtricitabine + Elvitegravir + Cobicistat is available in Tablet and strengths such as Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, TAF + Emtricitabine + Elvitegravir + Cobicistat is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

TAF + Emtricitabine + Elvitegravir + Cobicistat can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Genvoya is a once-daily, fixed-dose combination of Tenofovir Alafenamide (TAF) 10 mg, Emtricitabine 200 mg, Elvitegravir 150 mg, and Cobicistat 150 mg, used for the treatment of HIV-1 infection. Approved by the US FDA and EMA, Genvoya offers potent viral suppression with improved renal and bone safety compared to older TDF-based regimens like Stribild. It is indicated for treatment-naïve adults and adolescents (≥12 years, ≥35 kg) with no resistance to its components. The inclusion of Cobicistat enhances Elvitegravir and TAF levels, enabling effective once-daily dosing. Genvoya simplifies HIV therapy and improves adherence through its single-tablet formulation.